Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 26 | 33 | 24 | 35 | 43 |
| Gross Profit | 26 | 33 | 24 | 35 | 43 |
| Operating Expenses | 6,879 | 7,301 | 6,836 | 6,648 | 6,290 |
| Operating Income | -6,853 | -7,268 | -6,812 | -6,613 | -6,247 |
| Interest Expense | 280 | 279 | 285 | 203 | 0 |
| Other Income | 30 | 33 | 13 | 23 | 26 |
| Pre-tax Income | -7,103 | -7,514 | -7,084 | -6,793 | -6,221 |
| Net Income Continuous | -7,103 | -7,514 | -7,084 | -6,793 | -6,221 |
| Net Income Discontinuous | N/A | N/A | 8 | 219 | N/A |
| Net Income | $-7,103 | $-7,514 | $-7,076 | $-6,574 | $-6,221 |
| EPS Basic Total Ops | -0.33 | -0.36 | -0.34 | -0.33 | -0.31 |
| EPS Basic Continuous Ops | -0.33 | -0.36 | -0.34 | -0.34 | -0.31 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.01 | N/A |
| EPS Diluted Total Ops | -0.33 | -0.36 | -0.34 | -0.33 | -0.31 |
| EPS Diluted Continuous Ops | -0.33 | -0.36 | -0.34 | -0.34 | -0.31 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.01 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.33 | -0.36 | -0.34 | N/A | N/A |
| EBITDA(a) | $-6,774 | $-7,187 | $-6,653 | $-6,466 | $-6,099 |